We scan new podcasts and send you the top 5 insights daily.
Often called the "Berkshire of the North," Fairfax has mirrored Warren Buffett's model using insurance float, a decentralized structure, and shareholder-first culture. This strategy has resulted in an 18% compounded annual book value growth for nearly four decades.
For its first two decades, Fairfax's insurance underwriting was unprofitable (combined ratio >100%). Through disciplined management, it now operates at a ~97% ratio, turning its insurance float from costly capital into free, profitable leverage—a critical business model inflection point.
In an industry like insurance with few structural competitive advantages, founder Prem Watsa identifies culture as Fairfax's only true moat. Qualities like trust, fairness, humility, and long-term thinking differentiate the company, drive performance, and are nearly impossible for competitors to copy.
While a soft market slows premium growth, it also reduces the need for capital to back new business. This frees up significant cash flow for Fairfax to execute accretive buybacks and other capital returns, especially when the stock trades at a discount to its intrinsic value.
The book "The Fairfax Way" reveals the company's early success wasn't merely from acquiring insurers at low valuations. The critical, often overlooked element was the immense time, money, and work required to revamp and stabilize these acquired operations to an acceptable level, a key lesson for value investors.
Fairfax executed a brilliant capital allocation move by selling a 10% stake in its subsidiary, Odyssey, to pension funds for 1.7 times its book value. They then used the billion-dollar proceeds to buy back their own undervalued parent company stock, which was trading at a discount of 0.9x book value.
CEO Prem Watsa's salary has been frozen at $600k since 2000 with no bonuses. His main reward is the ~$19 million he earns in dividends from his ~10% ownership. This aligns his pay directly with long-term profitability and shareholder returns, not short-term metrics.
Fairfax maintains a balance sheet with roughly $75 billion in investments against $25 billion in equity. This leverage is primarily funded by low-cost insurance float and some debt, creating a powerful engine for returns that the speakers argue is a "better mousetrap than Berkshire."
Fairfax targets well-run insurers that invest their float conservatively for low returns (e.g., 4%). By applying its superior investment arm to boost the float's return (e.g., to 7%), it dramatically increases the acquired company's ROE without altering core underwriting operations.
Unlike Berkshire Hathaway's "buy and hold forever" approach, Fairfax partners with management teams and is often willing to sell a business if the managers decide it's the right time. This flexibility provides an additional tool for deal-making and capital recycling.
Despite compounding book value at ~20% annually, Fairfax's stock multiple has stagnated. The speakers argue this is because Canadian institutional managers, who are key investors, are selling due to slowing top-line premium growth, ignoring the underlying value creation.